Question

The following are major trends in reshaping pharmaceutical marketplace, EXCEPT

Answer 1

Answer:

where are the following major trends

please write them also

ok.....

Answer 2

if you think it will help you then mark it as the brainliest answer

Explanation:

seven major socio-economic trends.

1.The burden of chronic disease is

soaring. The prevalence of chronic

diseases like diabetes is growing

everywhere. As greater longevity forces

many countries to lift the retirement age,

more people will still be working at the

point at which these diseases start. The

social and economic value of treatments

for chronic diseases will rise accordingly,

but Pharma will have to reduce its

prices and rely on volume sales of such

products because many countries will

otherwise be unable to afford them.

2.Healthcare policy-makers and

payers are increasingly mandating

or influencing what doctors can

prescribe. As treatment protocols

replace individual prescribing decisions,

Pharma’s target audience is also

becoming more consolidated and more

powerful, with profound implications

for its sales and marketing model.

3.The industry will have to work much

harder for its dollars, collaborate with

healthcare payers and providers, and

improve patient compliance.

4.Pay-for-performance is on the rise.

A growing number of healthcare payers

are measuring the pharmacoeconomic

performance of different medicines.

Widespread adoption of electronic

medical records will give them the

outcomes data they need to determine

best medical practice, discontinue

products that are more expensive or less

effective than comparable therapies and

pay for treatments based on the outcomes

they deliver. So Pharma will have to prove

that its medicines really work, provide

value for money and are better than

alternative forms of intervention.

4.The boundaries between different

forms of healthcare are blurring. The

primary-care sector is expanding as

clinical advances render previously fatal

diseases chronic. The self-medication

sector is also increasing as more

prescription products are switched to

over-the-counter status. The needs

of patients are changing accordingly.

Where treatment is migrating from the

doctor to ancillary care or self-care,

patients will require more comprehensive

information. Where treatment is

migrating from the hospital to the

primary-care sector, patients will require

new services such as home delivery.

5.The markets of the developing world,

where demand for medicines is likely

to grow most rapidly over the next 13

years, are highly varied. Developing

countries have very different clinical and

economic characteristics, healthcare

systems and attitudes towards the

protection of intellectual property. Any

company that wants to serve these

markets successfully will therefore have

to devise strategies that are tailored to

their individual needs.

6.Many governments are beginning

to focus on prevention rather than

treatment, although they are not yet

investing very much in pre-emptive

measures. This change of emphasis

will enable Pharma to enter the realm

of health management. But if it is to do

so, it will have to rebuild its image, since

healthcare professionals and patients

will not trust the industry to provide

such services unless they are sure it has

their best interests at heart.

7.The regulators are becoming more

risk-averse. The leading national and

multinational agencies have become

much more cautious about approving

truly innovative medicines, in the wake

of problems with medicines like Vioxx.